SEC Form 4 · accession 0001615774-18-002790
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George C Carpenter IV
Officer — Chief Executive Officer
Period of report
Apr 19, 2018
Accepted (ET)
Apr 20, 2018 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 19, 2018 | A | 34,380 | $0.00 | A | 39,708 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The award of Common Stock was granted, and approved by the board of directors of MYnd Analytics, Inc. (the "Registrant"), as an amendment to the Employment Agreement dated September 7, 2007. The shares vests quarterly.